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Abstract
To measure the strength of natural selection that acts upon single nucleotide variants (SNVs) in a set of human genes, we
calculate the ratio between nonsynonymous SNVs (nsSNVs) per nonsynonymous site and synonymous SNVs (sSNVs) per
synonymous site. We transform this ratio with a respective factor f that corrects for the bias of synonymous sites towards
transitions in the genetic code and different mutation rates for transitions and transversions. This method approximates the
relative density of nsSNVs (rdnsv) in comparison with the neutral expectation as inferred from the density of sSNVs. Using
SNVs from a diploid genome and 200 exomes, we apply our method to immune system genes (ISGs), nervous system genes
(NSGs), randomly sampled genes (RSGs), and gene ontology annotated genes. The estimate of rdnsv in an individual exome
is around 20% for NSGs and 30–40% for ISGs and RSGs. This smaller rdnsv of NSGs indicates overall stronger purifying
selection. To quantify the relative shift of nsSNVs towards rare variants, we next fit a linear regression model to the estimates
of rdnsv over different SNV allele frequency bins. The obtained regression models show a negative slope for NSGs, ISGs and
RSGs, supporting an influence of purifying selection on the frequency spectrum of segregating nsSNVs. The y-intercept of
the model predicts rdnsv for an allele frequency close to 0. This parameter can be interpreted as the proportion of
nonsynonymous sites where mutations are tolerated to segregate with an allele frequency notably greater than 0 in the
population, given the performed normalization of the observed nsSNV to sSNV ratio. A smaller y-intercept is displayed by
NSGs, indicating more nonsynonymous sites under strong negative selection. This predicts more monogenically inherited or
de-novo mutation diseases that affect the nervous system.
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Introduction
A thorough understanding of sequence variation of human
genes is important to understand the molecular basis of human
disease. Many earlier studies had analyzed single nucleotide
variants (SNVs) in coding regions of human genes and demon-
strated a signature of purifying selection on nonsynonymous SNVs
(nsSNVs) by comparing their frequencies to synonymous SNVs
(sSNVs) [1–9]. Since then, the size of SNV datasets has increased
tremendously [10,11]. In the present manuscript, we quantify the
level of nsSNVs in different sets of genes as normalized by the
levels of sSNVs, using coding SNVs from two published whole
exome datasets [12,13]. We specifically focus on genes with
molecular roles in the immune and nervous system. On the
phenotype level, functional variants in these genes are most likely
to impact immune and nervous system traits. Insights into the
patterns of genetic variation in these genes therefore sheds light on
the genetic architecture of immune and nervous system pheno-
types.
Both the immune and the nervous system consist of a large
number of specialized cell types that function in strong interaction
with the environment. Comparative genomic studies show that
both human immune and nervous system genes are outliers in
terms of their sequence evolution. While immune system genes are
generally fast evolving genes [14,15] in mammals, nervous system
genes are highly conserved, but show accelerated evolution in
hominids [15,16]. The phylogenetic distribution of the respective
genes shows major genetic innovations in early vertebrates.
Nervous system gene families typically exist in invertebrates [17],
but overproportionally expanded in early vertebrates [18–20]. In
contrast, gene families underlying innate immunity arose before
the vertebrate-invertebrate split [21], whereas families underlying
adaptive immunity arose after this split [22]. With respect to more
recent human evolution, immune and nervous system genes are
known to display the least linkage disequilibrium and the highest
recombination rates in the human genome [23–25].
Taken together, these earlier results indicate that both human
immune and nervous system genes are particularly exposed to
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specifically ask how immune and nervous system genes compare
to each other and to other genes with respect to their levels of
functional variationinthehuman genome.Toaddressthis question
we obtain two sets of nervous system genes (NSGs) and immune
system genes (ISGs) based on expression data [26] and keyword
databasesearch[27].Wefurthercomparethesebroadlydefinedsets
of NSGs and ISGs with randomly sampled genes (RSGs) and with
gene ontology (GO) annotated genes. To quantify the level of single
nucleotidevariationinasetofgenes,wedefinetherelativedensityof
nonsynonymous variants (rdnsv) as compared with the neutral
expectationthatisinferredfromthedensityofsynonymousvariants.
Wefindthatrdnsvvariesamonggenesetsaswellasamongindividual
exomesandoverSNVallelefrequencies.Basedontheonthechange
of rdnsv over the allele frequency of underlying SNVs, we predict
greaterproportionsofstronglydeleterioussitesforNSGs,whichcan
explain more monogenic phenotype manifestations for the nervous
system as well as a greater importance of de-novo mutations. Our
analysis further supports widespread purifying selection on segre-
gating nsSNVs for nearly all groups of genes, including both NSGs
and ISGs. Thus, mildly deleterious nsSNVs are likely to play
a causative role in both groups of disease phenotypes. However,
certainsetsofISGsdisplayagreaterrdnsvestimatethanthegenomic
background, which supports the idea of an enhanced influence of
positive selectionon their frequency spectrum offunctional nsSNVs
andputativediseasevariants.Thisobservationcanexplainapossible
presence of more common disease variants for the immune system.
Methods
Analysis of Coding Sequence Variation
If natural selection would equally act on nonsynonymous as on
synonymous mutations, the value of rdnsv for a set of genes were
expected to equal 1. Vice versa, rdnsv were expected to equal 0, if
selection would not tolerate any nonsynonymous mutations to
segregate in the population at all. In reality, for most sets of gene
the value of rdnsv is likely to be between 0 and 1 and expected to be
shaped by natural selection in two ways: 1) by the proportion of
nsSites where any nsSNV with a frequency notably greater than
0 are not tolerated to segregate, and 2) by the effect of weak
selection on segregating nsSNVs at any of the remaining nsSites.
In the following we describe our approach to disentangle these two
factors based on an approximate estimate of rdnsv for a set of
human genes and chromosomes.
In order to derive a simple estimate of rdnsv, we view
synonymous sites (sSites) and nonsynonymous sites (nsSites) as
mutational opportunities. We calculate the number sSites and
nsSites in a set of genes as the sum over all possible single basepair
changes in the reference sequence based on the standard genetic
code. The total number of sites in a coding sequence is the sum
over all its sSites and nsSites. We use the coding regions from the
human genome assembly as reference sequence for each gene.
Nucleotides at partially degenerate sites with two synonymous and
one nonsynonymous mutational opportunities are counted as 2/3
sSite and 1/3 nsSite, whereas nucleotides with one synonymous
and two nonsynonymous mutational opportunities are counted as
1/3 sSite and 2/3 nsSite. Nucleotides at fourfold degenerate
positions are counted as 3/3 sSite, whereas nucleotides at non-
degenerate positions are counted as 3/3 nsSite. We normalize the
observed numbers of nsSNVs and sSNVs by calculating the rate of
nsSNVs per nsSite (Rn) and the rate of sSNVs per sSite (Rs), e.g.
Rn=nsSNV/nsSite and Rs=sSNV/sSite. However, the genetic code
is enriched for transitions among synonymous changes and
transition mutations are more likely to occur than transversion
mutations. To estimate the relative density of nsSNVs as
compared with the neutral expectation (rdnsv) as inferred from
the density of sSNVs, we therefore need to correct the Rn/Rs ratio
for the influence of the genetic code on synonymous and
nonsynonymous mutation rates.
Here we approach this task by deriving a respective correction
factor f from the observed numbers of transition and transversion
sites that are synonymous or nonsynonymous sites as compared
with the respective numbers of sites that were expected for
a random genetic code. Based on our definition of sites as
mutational opportunities, we can view each basepair as 1/3
transition site and 2/3 transversion site, because it allows for one
transition and two transversion mutations. The number of
transition sSites (sSitets) can then be calculated by summing up
all opportunities for single basepair mutations in the reference
sequence that are both synonymous and transitions. Analogously,
we can calculate the numbers of transition nsSites (nsSitets),
transversion sSites (sSitetv) and transversion nsSites (nsSitetv). One
may now assume that at any specific basepair a transition
mutation is 4 times more likely to occur than a transversion
mutation during an arbitrary time unit, based on a 2-fold higher
rate per basepair for transition mutations (i.e. a transition/
transversion mutation rate ratio of 2) and each basepair allowing
for only 1 transition, but 2 transversion mutational opportunities.
We can then adjust the Rs values based on the ratio between
observed and expected proportions of transitions among sSites.
More formally we can write:
fs~
sSitets
sSite
|4rtvz
sSitetv
sSite
|rtv
 
1
3
|4rtvz
2
3
|rtv

ð1Þ
where rtv denotes the rate of transversion mutations (with 4 rtv=rts),
and sSitets/sSite and sSitetv/sSite denote the proportions of sSites that
are transition or transversion sites.
In the reference genome sequence, we observe (in all evaluated
gene categories) that transition sites constitute close to 1/2 of all
sSites (i.e. sSitets/sSite , 0.5 instead of a ratio of sSitets/sSite=1/3
that were expected for randomly distributed transition and
transversion sites) (Table S1). Based on these observed counts of
sites, this leads to fs=1.25, which indicates a 25% increase of the
synonymous mutation rate that is attributable to the structure of
the genetic code. Thus, the rate of sSNVs per sSite that would be
expected with a random genetic code can be obtained by dividing
the observed Rs value by fs. The fraction of sSites that are
transition and transversion sites is very similar across our sets of
candidate genes (Table S1).
To compensate for the increased proportion of transition sites
among sSites a corresponding decreased proportion must exist
among nsSites. Accordingly, we further observe in the human
genome reference sequence a proportion of 4/14 of nsSites being
transitionsites(i.e.nsSitets/nsSite,0.285)insteadoftheexpected1/3.
(Table S1). When applying now the analog reasoning for nsSites as
above for sSites, this leads to an estimated overall reduction of the
nonsynonymous mutation rate by 7.5% due to the structure of the
geneticcode.Thus,theobservedRnvaluesneedtobedividedbythe
factor fns=0.925 to estimate the rate of nsSNVs per nsSite that
wouldbeexpectedwitharandomgeneticcode.Incombinationwith
the above correction factor fs, one may therefore estimate that the
structure of the genetic code reduces the nonsynonymous mutation
rate relative to the synonymous mutation rate by the factor:
f~fs=fns~1:35 ð2Þ
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a correction for the biased structure of the genetic code.
Accordingly, we can now estimate the relative density of
nonsynonymous variants:
rdnsv~f|
Rn
Rs
ð3Þ
Based on the above definition of Rn and Rs this is furthermore
equivalent to:
rdnsv~f|
sSite
nsSite
|
nsSNV
sSNV
ð4Þ
Because the ratio sSite/nsSite is ,0.3 for the gene sets analyzed here
(Table S1), a simple rule of thumb to approximate rdnsv for large
gene sets is given by multiplying the ratio of nsSNV/sSNV by
f’=0.4 (> 0.3 f).
rdnsv%f|0:3|
nsSNV
sSNV
ð5Þ
To analyze the dependency of rdnsv on the allele frequency of
SNVs,wecalculaterdnsvseparatelyfordifferentallelefrequencybins
of SNVs (frequency below 2%, 5%, 10%, 20%, 40%, 80% and
95%).Wethenfitalinearregressionmodeltothevaluesofrdnsvover
the allele frequency. We logarithmically transform the allele
frequency variable, because the frequency spectrum of human
SNVs is known to be strongly shifted towards rare variants [12,28].
In the fitted regression model, two predicted values of rdnsv deserve
particular attention: First, the y-intercept (rdnsv0), which gives the
relative density of nsSNVs for an allele frequency near 0. The
estimate of rdnsv0 thus approximates the proportion of nonsynon-
ymous mutations that are not immediately rejected by selection out
of all nonsynonymous mutations, assuming that sSNVs evolve
neutrally and the normalization of the ratio nsSNV/sSNV for
different underlying nonsynonymous and synonymous mutation
rates. This proportion equals the proportion of nonsynonymous
mutations that occur on neutral nsSites or weakly deleterious
nsSites, which is the proportion of nsSites where nsSNVs are
tolerated to segregate in the population. Vice versa, 1- rdnsv0 (the
difference between the expected intercept under the absence of
selectionandtheobservedintercept)approximatestheproportionof
nsSites (out of all nsSites), where nsSNVs are not tolerated to
segregateevenatverylowfrequency.Thesecondpredictedvalueof
interest (rdnsv1) is the relative density of nsSNVs near the allele
frequency 1. This value rdnsv1 approximates the proportion of
nsSites where purifying selection does not prevent nsSNVs from
reachingfixation.Thus,estimatingrdnsv0andrdnsv1forasetofgenes
mayhelptoseparatetheinfluenceofselectionatstronglydeleterious
versusmildlydeleteriousandneutralsites.Bothfactorscontributeto
the overall value of rdnsv in a sample of chromosomes, but only the
latter influences the allele frequency spectrum of nsSNVs.
We first apply our method to SNVs from a diploid European
genome sequence as produced by traditional Sanger sequencing,
which are obtained from the annotation track pgVenter in the
UCSC genome database [13,29]. We then apply the method to
whole exome SNV data from 200 Danish individuals that are
downloaded from the Beijing Genomics Institute (BGI) website
[12]. We calculate the derived allele frequency based on the status
of chimp alleles, which we obtain from the human-chimp BlastZ
alignment in the UCSC database. If no chimp allele was available,
the minor allele was taken as the most likely derived allele (which
applies to 2.6% of the SNVs). Those SNVs from the exome dataset
that cannot be lifted to the NCBI37 assembly with the UCSC
liftOver tool are excluded. In both SNV datasets, sSNVs and
nsSNVs are defined based on the positions of SNVs in the UCSC
gene models. Both missense and nonsense SNVs are counted as
nsSNVs.
Definition of Candidate Genes
Transcripts for human autosomal genes are obtained from the
‘knownGenes’ and ‘knownCanonical’ annotation tracks of the
University of California Santa Cruz (UCSC) genome database
[29]. Genes with specific roles in the immune system (in the
following referred to as ISGs) and the nervous system (in the
following referred to as NSGs) are obtained based on the GNF2
expression dataset [26]. The 1500 genes specifically expressed in
the greatest number of immune tissues and the 1500 genes
specifically expressed in the greatest number of nervous system
tissues, respectively, are taken as candidate genes. Because these
sets of candidate genes are defined by the specific expression in
disjunctive sets of tissues, no great overlap would be expected.
Consistently, only four genes (EVI2A, DOCK10, C9orf103, PTK2B)
belong to both sets and are removed from the subsequent analysis.
Expression analyses for 16185 autosomal human genes are based
on 62 out of the 79 tissues from the GNF2 dataset represented in
UCSC database (table gnfHumanAtlas2Median), excluding dis-
ease, compound and fetal tissues [26]. Raw expression values are
log2 transformed and for each gene subsequently normalized by
a Z-score transformation across all included tissues. Genes with Z-
scores greater 1.0 are considered as specifically expressed in
a tissue. Nervous system tissues are defined by the labels temporal
lobe, parietal lobe, occipital lobe, prefrontal cortex, cingulated
cortex, cerebellum, cerebellum peduncles, amygdala, hypothala-
mus, thalamus, subthalamic nucleus, caudate nucleus, globus
pallidus, olfactory bulb, pons, medulla oblongata, spinal cord,
ciliary ganglion, trigeminal ganglion, superior cervical ganglion,
dorsal root ganglion. Immune tissues are defined by the labels
thymus, tonsil, lymph node, BM CD33pos myeloid, PB BDCA4-
pos dentritic cells, PB CD14pos monocytes, PB CD56pos
NKCells, PB CD4pos Tcells, PB CD8pos Tcells, PB CD19pos
Bcells. We find nervous system candidates specifically expressed in
an average of 10.5 out the 21 nervous system tissues, 0.27 immune
system tissues and 1.7 out of the remaining 31 other tissues.
Immune system candidates are specifically expressed in an average
of 7 out of the ten immune tissues, 0.6 nervous system tissues and
3.6 other tissues. Thus, both groups of candidate genes show
roughly the same level of overall expression specificity, making
a confounding effect of this variable unlikely. We additionally
compare these functional candidate genes to a disjoint and equally
sized set of random ‘non-candidate genes’, which all have GNF2
expression annotations.
A second set of functional candidate genes is obtained by
keyword search with the term ‘(neuronal* or glial* or neural* or
neurite or axon) and not olfactory’ and the term ‘immune* or
immunological*’from Entrez Gene [27] (version 09/10). The
retrieved genes are linked to known UCSC genes by their official
gene names. This keyword search of gene annotations provides us
with a list of 1334 ISGs and a list of 1817 NSGs. Of these genes,
294 genes are contained in both lists of keyword-based candidates
and therefore removed from the analysis. A total of 367 genes from
the remaining 1523 keyword-based NSGs is also included in the
above list of expression-based NSGs, whereas a total of 181 from
the remaining 1040 keyword-based ISGs is also included in the
above expression-based ISGs.
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permutations of the category status and counting how often
a greater difference of the test statistic (e.g. Rn, Rs or Rn/Rs)i s
observed in the permuted than the observed data. The expected
background values are calculated as the 2.5% and 97.5% quantiles
from 10.000 sets of 1500 randomly sampled genes.
Monogenic disease gene annotation are obtained from the
‘morbidmap’ file of the Online Mendelian Inheritance in Men
(OMIM) database (version 03/10). Complex disease locus
annotations come from the file ‘GWASCatalog’ from the National
Human Genome Research Institute (NHGRI) Genome Wide
Association Study (GWAS) catalog website (version 03/10). The
morbidmap and GWASCatalog files are manually searched for
entries linked to immune or nervous system phenotypes. All
complex disease loci from OMIM are discarded. Also GWASCa-
talog loci with P.5*10
28 are discarded. Nervous system
phenotypes are defined as those affecting the nervous system,
including both psychiatric and neurological disorders. Immune
phenotypes are defined as those that relate to dysfunction of the
immune system, including autoimmune disease and susceptibility
to infection. Gene ontology (GO) annotations of human genes are
obtained from the GO- database. [30].
Results
Relative Density of nsSNVs in Individual Exomes
We start by looking at SNVs in nervous system genes (NSGs)
and immune system genes (ISGs) from the exome of an individual
diploid genome sequence [13], with NSGs and ISGs being defined
by their specific expression in the respective tissues. These
expression-based candidates are further compared with an equally
sized set of randomly sampled genes (in the following referred to as
RSGs), which do not overlap with ISGs and NSGs. To evaluate
the level of SNVs in these candidate genes, their different coding
sequence length needs to be considered (Figure S1a). Therefore,
we calculate the rate of nsSNVs per nsSite (Rn) and the rate of
sSNVs per sSite (Rs) for each set of genes (Table S2a). We further
normalize Rn by Rs and find that NSGs have a significantly
reduced Rn/Rs ratio as compared with ISGs and RSGs (P,10
25).
The Rn/Rs ratio accounts for possible differences read coverage,
SNV call rates or mutation rate between gene categories, because
these factors would equally affect the density of nsSNVs and
sSNVs as measured by Rn and Rs in a gene category.
However, to additionally relate the Rn/Rs ratio to the neutral
expectation, it is important to consider that transition mutations
occur with higher likelihood than transversion mutations and that
transitions are enriched among synonymous changes in the genetic
code [31]. Here we correct for this nonsynonymous to synony-
mous mutation rate bias by multiplying the observed Rn/Rs ratio
with a respective factor f that is defined by equation (2) in the
Materials and Methods. This strategy is designed to estimate the
relative density of nonsynonymous variants as compared with
neutral expectation (rdnsv) as defined above by equation (3). We
estimate rdnsv to be around 20% in NSGs, around 31% in ISGs
and around 38% in RSGs with the SNVs from the diploid genome
(Figure 1a, Table 1a). We next retrieve a second set of candidate
genes through keyword search of the EntrezGene database [27].
These keyword-based candidates may differ from the expression-
based candidates in the sense that they are more likely to have
been experimentally studied in detail. When analyzing the SNVs
from the diploid genome in these keyword-based candidates, the
estimates of rdnsv are ,21% in NSGs and ,41% in ISGs
(Figure 1c, Table 1a). Thus, also keyword-based NSGs again
display a significantly (P,10
25) smaller level of nonsynonymous
variation than ISGs (Table S2b).
To further expand these observation into a larger SNV dataset,
we use a published dataset of 200 human exomes [12]. We first
separately calculate rdnsv for each of the individual exomes, which
shows rdnsv to be roughly normally distributed. The estimates of
rdnsv are consistently smaller for NSGs than ISGs (Figure 2). The
Figure 1. Relative density of nsSNVs (rdnsv) in different gene sets as estimated with different SNV datasets. Nervous system genes
(NSG, light grey) show a smaller rdnsv than immune system genes (ISG, medium grey) or randomly sampled genes (RSG, dark grey) in a European
diploid genome sequence (A, C) and a pooled set of 200 European exome sequences (B, D). The greater rdnsv in the pooled 200 exomes than the
individual genome indicates an enrichment of nsSNVs among rare SNVs.
doi:10.1371/journal.pone.0038087.g001
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exomes (20.1% and 29.0% for expression-based NSGs and ISGs
and 19.8% and 39.3% for keyword-based NSGs and ISGs) are
close to the corresponding rdnsv values from the diploid genome
above, despite the fact the diploid genome was obtained under
a rather different experimental protocol. Consistent with the
diploid genome, we see a greater heterogeneity between expres-
sion- and keyword-based ISGs than the two types of NSGs.
It is important to note that the sampling of 400 instead of 2
chromosomes at each site causes an ascertainment of more rare
SNVs. Because nsSNVs are enriched among rare SNVs, the
estimatesofrdnsvinthepooled200exomesaregreaterthanthosefor
thediploidgenomeinallthreegenecategories(Figure1).Acrossthe
pooled dataset of 200 exomes, we estimate for expression-based
candidates that rdnsv is ,33% in NSGs, ,39% in expression-based
ISGs and ,42%in RSGs, whereas for expression-based candidates
it is 31% for NSGs and 47% for ISGs (Table 1a). Nevertheless, we
again see that rdnsv is significantly smaller in NSGs than ISGs or
RSGs (P,10
23), which applies to both expression-based and
keyword-based candidates (Tables S2c, S2d).
To define the range of expected values of rdnsv for arbitrary sets
of genes, we further randomly draw 10.000 sets of 1500 autosomal
genes. This shows that both expression-based and keyword-based
NSGs are at the low end of the range of rdnsv estimates (Table 1a).
When comparing expression-based and keyword-based ISGs to
each other, we see that the former tend to fall at the lower end of
the range of rdnsv estimates, whereas the latter tend to fall on the
upper end. Consistent with this greater heterogeneity of the two
sets of ISGs than the two sets of NSGs, we see greater difference of
the coding sequence length between the former than the latter two
sets of genes (Figure S1b).
Relative Density of nsSNVs as Stratified by Population
Allele Frequency
When rdnsv is estimated in a diploid genome or a pooled set of
chromosomes, its value reflects the level of nonsynonymous
variation on a mixture of SNVs that range from rare to common
in their population frequency. To additionally exploit the in-
formation that is contained in the change of rdnsv with allele
frequency, we next group SNVs into disjoint frequency bins and
separately estimate for each bin its rdnsv value in the pooled set of
200 exomes. This shows that expression-based NSGs display
a reduced rdnsv value across all frequency bins (Figure 3a). When
we further estimate rdnsv for our keyword-based candidate genes,
we again see smaller rdnsv values for NSGs across all bins
(Figure 3b). Additionally, rdnsv tends to decrease with SNV allele
frequency in all sets of candidate genes.
To further capture this influence of allele frequency on rdnsv,
we next fit a regression model to the estimates of rdnsv over the
allele frequency of underlying SNVs in the 200 exome data. The
y-intercept parameter (rdnsv0) of the model might be best
interpreted as the proportion of nsSites where variants are
tolerated to segregate with frequency greater 0 and thus do not
cause any highly detrimental consequences. Analogously, we
might interpret the predicted value for a derived allele frequency
near 1 (rdnsv1) as the proportion of nsSites where mutations are
not prevented from reaching fixation. In our candidate genes, we
see that rdnsv0 and rdnsv1 equal 45% and 17% for expression-
based NSGs, whereas they equal 58% and 21% for expression-
based ISGs (Table 1b). For keyword-based NSGs we find that
rdnsv0 and rdnsv1 equal 43% and 15%, whereas they equal 58%
and 37% for keyword-based ISGs. Thus, both rdnsv0 and rdnsv1
are highly similar between expression- and keyword-based NSGs.
In contrast, the two sets of ISGs display only similar estimates of
rdnsv0, but quite different estimates of rdnsv1. The inspection of
the fitted models shows that the y-intercept is significantly
different from its theoretically expected value of 1 (P,0.001) and
that the slope is significantly different from 0 (P,0.01) in all
candidate sets. The coefficient of determination R
2 varies from
0.61 (expression-based NSGs) over 0.70 (keyword-based ISGs)
and 0.78 (expression-based ISGs) to 0.85 (keyword-based NSGs),
indicating that the models capture the dependency of rdnsv on
SNV allele frequency. However, it can also be seen that the
residual deviation from the fitted models consistently attains
a relatively large value for the lowest frequency bin, which might
indicate some non-linearity.
To relate the observed rdnsv0 and rdnsv1 of our candidate genes
to their expected values, we further compare them with 10.000
draws of random genes sets (Table 1b). For expression-based and
keyword-based NSGs we see that rdnsv0 and as a consequence also
rdnsv1 fall at the low end of values. On the other hand, rdnsv1 of
expression-based ISGs tends to fall towards the lower end, whereas
rdnsv1 of keyword-based ISGs falls towards the upper end of values.
Notably, both these sets of ISGs display rdnsv0 similar to random
gene sets. Thus, NSGs consistently stand out by their small rdnsv0,
whereas the noted heterogeneity between expression-based and
keyword-based ISGs becomes visible in a different slope, but not
a different intercept of the two regression models.
Table 1. Relative density of nonsynonymous variants (rdnsv).
RSG expression ISG expression NSG keyword ISG keyword NSG
#genes 1496 1496 1496 1040 1523
A)
rdnsv (diploid genome) 0.38 [0.31–0.39] 0.31 0.20 0.41 0.21
rdnsv (200 exomes) 0.42 [0.39–0.45] 0.39 0.33 0.47 0.31
B)
rdnsv0 (200 exomes) 0.58 [0.53–0.65] 0.58 0.45 0.58 0.43
rdnsv1 (200 exomes) 0.25 [0.21–0.29] 0.21 0.17 0.37 0.15
Candidate genes for the nervous system (NSG) and the immune system (ISG) are defined by tissue specific expression or keyword search and further compared with a set
of randomly sampled genes (RSG). A) Overall rdnsv estimates for a diploid genome and 200 exome sequences, which reflect the density of nonsynonymous variants on
a mixture of SNVs that range from rare to common in their population frequency. B) SNVs from the 200 exome dataset are additionally stratified by their derived allele
frequency and a regression model is fitted to the values of rdnsv. The predicted value for the allele frequency of 0 is referred to as rdnsv0, whereas the predicted value
for the allele frequency of 1 is referred to as rdnsv1. The interval in brackets shows the 2.5% and 97.5% quantiles from 10.000 random draws of genes.
doi:10.1371/journal.pone.0038087.t001
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defined candidate genes compare to the rdnsv of gene sets with more
specific molecular annotations. To address this question we
retrieved allsetsofgene ontology(GO)annotatedgenesthat harbor
at least 1000 coding SNVs in the 200 exome dataset. We then
estimateforeachGO-categoryitsmeanvalueofrdnsvacrossthe200
exomes as well as its values of rdnsv0 and rdnsv1 from the respective
regression models over the allele frequency strata (Table S3). This
shows several GO-categories for nervous system functions (e.g.
GO:0048812, GO:0007409, GO:0045202) to belong to those with
thesmallestlevelofnonsynonymousvariation(Table2a).Consistent
with the above results for expression-based and keyword-based
NSGs,seethatrdnsv0isreducedinnervoussystemgenes.Inaddition,
GO-categories related to tyrosine kinase signaling (GO:0007169,
GO:0007167)displaythelowestlevelsofnonsynonymousvariation.
It remains to be found out, whether this reduction constitutes
afeaturethatisgenuinetotyrosinekinasesignalinggenesorwhether
it is driven by their functions in nervous system cells.
On the other end of the spectrum, we see the highest level of
nonsynonymous variation for GO-categories related to olfactory
receptor function (GO:0004984, GO:0004930) as well as immune
system function (GO:0006955, GO:0006952) (Table 2b). GO
‘olfactory receptor’ genes display both rdnsv0 and rdnsv1 values
fairly close to 1, i.e. both rdnsv0 and rdnsv1 account for the increased
overall rdnsv in individual exomes. In contrast, GO ‘immune
response’ genes show rdnsv0 values roughly equal to random gene
sets, but greater rdnsv1 values, which is similar as seen for keyword-
based ISGs. These observations suggests that the high overall rdnsv
of ‘olfactory receptor’ genes is largely due to relaxed constraint,
Figure 2. Distribution of rdnsv estimates over 200 individual exomes. A) expression-based candidate genes and B) keyword-based candidate
genes. The value of rdnsv is estimated separately for each of the 200 exomes and found consistently smaller for NSGs (light grey) are than ISGs
(medium grey). In addition, smaller estimates of rdnsv for expression-based ISGs than keyword-based ISGs are seen. No difference exists between
expression-based NSGs and keyword-based NSGs.
doi:10.1371/journal.pone.0038087.g002
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be due to an influence of positive selection.
Discussion
We devise a method for estimating the relative density of
nonsynonymous variants as compared with the neutral expectation
(rdnsv), which we apply to two separate exome datasets [12,13]. We
notice that rdnsv shows relatively small differences between in-
dividual exomes, but strong difference between gene categories. To
capture thedependency ofrdnsv ontheallele frequency ofSNVs,we
fit a regression model to the values of rdnsv as stratified by the
frequencyofSNVs.Weinterprettheslopeofthismodelasameasure
of the overall strength of selection on segregating nsSNVs. The y-
intercept of this model (rdnsv0) may be interpreted as a prediction of
the proportion of nsSites (among all nsSites) where mutations are
tolerated to segregate in the population.
We use our method to measure the levels of nonsynonymous
variants (nsSNVs) among human nervous system genes (NSGs),
immune system genes (ISGs), randomly sampled genes (RSGs) and
GO-annotated genes. That rdnsv is consistently reduced for NSGs
is indicating stronger purifying selection. We find that the reduced
overall rdnsv values of NSGs are paralleled by smaller estimates of
rdnsv0. This smaller rdnsv0 predicts greater proportions of nsSites
that are intolerant to mutations as an important cause for the
reduced overall rdnsv. Such a prediction of a greater proportion of
Figure 3. Estimates of rdnsv over different allele frequency bins. The estimates of rdnsv decrease with SNV allele frequency in all gene
categories. The slope of the fitted regression model can be interpreted as a measure for the influence of purifying selection on segregating nsSNVs.
The y-intercept (rdnsv0) can be interpreted as the proportion of nsSites where mutations are tolerated to segregate with an allele frequency notably
greater than 0. A) Expression-based NSGs (circles), ISGs (triangles) or RSGs (crosses). The fitted models are rdnsv(NSG)=0.4520.0616;
rdnsv(ISG)=0.5820.0796 and rdnsv(RSG)=0.5820.0716B )K e y w o r db a s e dN S G s( b l u e )a n dI S G s( r e d ) .T h ef i t t e dm o d e l sa r e
rdnsv(NSG)=0.4320.0616; rdnsv(ISG)=0.5820.0456.
doi:10.1371/journal.pone.0038087.g003
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38087strongly deleterious nsSites in NSGs is consistent with the high
frequency of neurological symptoms among undiagnosed disease
phenotypes [32] as well as the greater number of established
monogenic disease genes in the OMIM database. Based on an
analysis of the OMIM database [33], about 2.4 as many
monogenic disease genes for the nervous system than the immune
system have been discovered (326 to 135). In contrast, about 3.8 as
many susceptibility loci were identified for immune phenotypes
than nervous system phenotypes (122 to 32), based on the NHGRI
GWAS catalog [34] (Figure S2). Our present study demonstrates
how these different rates of monogenic disease manifestations for
different phenotypes are reflected in the sequence variability
patterns of a population-based sample. The reduced level of
nonsynonymous variation in NSGs is also consistent with the
strong conservation of such genes among mammals [15,35]. The
presented analysis additionally suggests that a greater proportion
of mutation intolerant sites has made a major contribution to the
increased interspecies conservation. Stronger purifying selection
on nervous system genes could be caused by the functional
complexity of neuronal cells and the developmental complexity of
the nervous system. A larger proportion of highly deleterious
nsSites in NSGs is further consistent with the role of exomic de-novo
mutations in mental retardation [36], schizophrenia [37], and
autism [38–40].
On the other hand, it has been hypothesized that functional
variants in immune genes are more often positively selected due to
pressures that were imposed by infectious agents [15,41–44]. Here
we see that rdnsv values are increased for certain sets of ISGs (i.e.
keyword-based ISGs and GO-immune response genes). Impor-
tantly, any influence of positive selection would not be expected to
influence the intercept (rdnsv0) of the regression models, because it
would alter the allele frequencies of segregating SNVs and not the
proportion of nsSites that tolerate mutations. Instead, the slope of
the model reflects the overall strength of selection on segregating
nsSNVs, which influences the proportion of nsSites where nsSNVs
may become fixed (rdnsv1). Therefore, it is interesting that the
greater overall rdnsv for certain types of ISGs in individual exomes
is paralleled by an increased estimate of rdnsv1, but not an
increased rdnsv0. This seems to support positive selection over
relaxed constraint as possible explanation. Although more
prevalent positive selection in ISGs may contribute to the presence
of more common nsSNVs and putative disease variants, it
nevertheless needs to be pointed out that all tested sets of
immunological genes still display a negative slope parameter. This
is consistent with a general importance of purifying selection for
the frequency spectrum of segregating nsSNVs in ISGs too. It
remains to be found out in future studies, which molecular subsets
of ISGs are more likely to harbour SNVs that are influenced by
positive selection and whether the observed heterogeneity might
be due to differences between genes that function in the innate and
the adaptive immune system.
It is important to distinguish our approach for analyzing the
level of nonsynonymous variation from methods for calculating the
Ka/Ks ratio that are widely employed in comparative genomic
studies [45]. In particular, one may want to compare our
normalization strategy to approximate methods for calculating
Table 2. Estimates of rdnsv in the 200 exomes in sets of genes as defined by ontology (GO) annotations.
Gene Ontology (GO) category genes nsSNVs sSNVs mean rdnsv sd rdnsv rdnsv0 rdnsv1
A)
GO:0007169:transmembrane_receptor_tyrosine_kinase_signaling 313 365 636 0.121 0.011 0.385 0.072
GO:0007167:enzyme_linked_receptor_protein_signaling_pathway 394 466 771 0.128 0.01 0.397 0.095
GO:0006935:chemotaxis 337 405 669 0.136 0.01 0.401 0.094
GO:0048812:neuron_projection_morphogenesis 326 445 703 0.139 0.011 0.396 0.11
GO:0007409:axonogenesis 303 420 664 0.141 0.012 0.397 0.11
GO:0031175:neuron_projection_development 368 510 795 0.143 0.011 0.4 0.119
GO:0048667:cell_morphogenesis_involved_in_neuron_differentiation 322 446 694 0.146 0.012 0.397 0.12
GO:0043005:neuron_projection 411 587 831 0.15 0.01 0.484 0.1
GO:0045202:synapse 326 477 633 0.151 0.013 0.544 0.089
GO:0048666:neuron_development 436 578 890 0.153 0.011 0.399 0.126
B)
GO:0005815:microtubule_organizing_center 277 542 484 0.344 0.025 0.5 0.399
GO:0005576:extracellular_region 1322 2281 1948 0.345 0.012 0.644 0.341
GO:0006952:defense_response 525 764 691 0.351 0.022 0.556 0.345
GO:0006955:immune_response 500 696 625 0.357 0.023 0.533 0.393
GO:0004871:signal_transducer_activity 1170 2350 1994 0.4 0.016 0.586 0.369
GO:0004872:receptor_activity 1233 2710 2218 0.406 0.015 0.615 0.368
GO:0038023:signaling_receptor_activity 913 2046 1583 0.456 0.019 0.624 0.43
GO:0004888:transmembrane_signaling_receptor_activity 844 1991 1489 0.466 0.02 0.654 0.437
GO:0004930:G-protein_coupled_receptor_activity 604 1469 890 0.603 0.029 0.741 0.573
GO:0004984:olfactory_receptor_activity 310 1024 430 0.896 0.048 1.011 0.993
The 10 GO-categories with the smallest (A) and the greatest (B) mean values of rdnsv are shown. The full list of all GO-categories with at least 1000 coding SNVs is given
in Table S3. For each category the number of annotated genes, nonsynonymous and synonymous SNVs, the mean and standard deviation of individual rdnsv estimates
across the 200 exomes, as well as the values of rdnsv0 and rdnsv1, are shown.
doi:10.1371/journal.pone.0038087.t002
A Simple Method to Analyze Nonsynonymous Variation
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38087the Ka/Ks ratio under a two parameter model with different rates
of transitions and transversions [46,47]. However, our method is
designed to evaluate variants from individual human genome
sequences, whereas Ka/Ks ratio methods are designed to analyze
fixed differences between sequences that are millions of years apart
and connected by a phylogenetic tree. From a technical point of
view, different mutational pathways between codons and recurrent
mutation of a same site have to be considered for comparative
genomic data, but not for human SNV data. On the other hand,
no consistent phylogenetic tree exists for a set of individual human
genome sequences. Therefore, a different set of methods has to be
used to analyze SNV data.
To our knowledge, the proposed approach has not been used
before to analyze individual genome data. Our estimates of the
proportions of nsSites that are tolerant and intolerant to mutations
are consistent with earlier studies that estimated the proportions of
neutral, weakly and strongly deleterious nsSites in human genes by
different methods [9,12,48] and from human and chimp
comparison [15]. In addition, the confidence in our normalization
procedure may be strengthened by the estimates of rdnsv close to 1
for olfactory receptor activity genes, because those genes are
known to be degenerating in the human lineage and evolve largely
neutral [49]. Nevertheless, it may be kept in mind that some
uncertainty is introduced by the assumption that sSNVs evolve
neutrally, which might not always be the case due to selection on
synonymous mutations [50] or background selection [51]. Also it
might be possible to refine the method by taking hypermutability
of CpG sites into account [52]. However, these factors do not alter
the comparison of sets of genes, as long as they influence nsSites
and sSites homogeneously across categories. Furthermore, one
might try to advance the approach by fitting more complex
statistical models than a regression line over the frequency
stratified rdnsv estimates. In this context, it is noteworthy that the
rdnsv estimate for the lowest allele frequency consistently shows
a relatively large positive deviation from the linear model across
the analyzed genes sets. This could indicate a non-linearity that
might be better captured by a more complex model that may be
fitted to larger SNV datasets becoming available in future.
However, it might also be influenced by a higher false positive
SNV call rate in the lowest frequency bin, what may also be
considered by subsequent modeling approaches.
In conclusion, we propose a novel statistical method that
estimates the relative density of nonsynonymous variants (rdnsv)i n
a set of human genes. We are convinced that in many situations
any possible sources of impreciseness are outweighed by the
advantage of its practical simplicity (in the simplest form,
multiplying an observed ratio between nsSNVs and sSNVs by f’
(,0.4) and plotting this transformed ratio over the allele
frequency). Using this method we explain here, why the nervous
system is more often affected by monogenic diseases than the
immune system. We would expect that the described method will
turn out to be useful for other questions too.
Supporting Information
Figure S1 Mean number of coding nucleotide sites per
gene for different sets of candidate genes. a) Expression-
based candidates and b) keyword-based candidates. Sites are
defined as mutational opportunities in the reference sequence.
Sites are stratified as nonsynonymous (dark grey) and synonymous
(light grey). The mean number of nonsynonymous and synony-
mous sites is greater in nervous system genes than immune system
genes or random genes. Error bars denote two standard errors of
the mean.
(PDF)
Figure S2 Number of monogenic disease genes from the
OMIM database and complex disease loci from the
GWAS-catalog (both queried 03/10). Nervous system
phenotypes are more often linked to monogenic disease genes
and therefore have more entries in OMIM (dark grey bars). Vice
versa, immune system phenotypes are more often linked to
complex susceptibility loci and therefore have more entries in the
GWAS-catalog (light grey bars).
(PDF)
Table S1 Number of synonymous and nonsynonymous
sites in different sets of genes in the human genome
reference sequence. Sites are defined as mutational opportu-
nities in the coding sequence of genes. Sites may be classified
synonymous (sSite) or nonsynonymous (nsSite). In a similar sense,
each site can be a transition site or transversion site. Among sSites,
the ratio of transition and transversion sites (sSitets/sSitetv) is close to
1, whereas among nsSites this ratio (nsSitets/nsSitetv) is close to 0.4.
Candidate genes for the nervous system (NSG) and the immune
system (ISG) are defined by tissue specific expression and keyword
search and further compared with randomly sampled genes
(RSG).
(PDF)
Table S2 Number of SNVs in different sets of candidate
genes in the diploid genome and 200 exomes. For each
gene set, its total number of nsSNVs and sSNVs, its rate of
nsSNVs/nsSite (Rn) and its rate sSNVs/sSite (Rs) are shown. Immune
System Genes (ISG) and a set of randomly sampled genes (RSG)
are compared to nervous system genes (NSG) based on 10,000
permutation of gene category labels. The intervals for RSGs in
square brackets show the 2.5% and 97.5% quantiles from 10.000
random draws of genes. To further estimate the relative density of
nsSNVs (rdnsv) from the Rn/Rs ratio, the respective correction
factor f needs to be applied, which is described in the main text.
(PDF)
Table S3 Estimates of rdnsv in the 200 exomes in sets of
genes as defined by ontology (GO) annotations. For each
category the number of annotated genes, nonsynonymous and
synonymous SNVs, the mean and standard deviation of individual
rdnsv estimates across the 200 exomes, as well as the values of rdnsv0
and rdnsv1, are shown.
(PDF)
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